PortfoliosLab logoPortfoliosLab logo

Janus Henderson Global Life Sciences Fund Class T (JAGLX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with JAGLX. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to JAGLX

JAGLX charges 0.92% annually. There are 23 mutual funds in the Health & Biotech Equities category with lower expense ratios, going as low as 0.09%.


Best Risk-Adjusted Alternatives to JAGLX

JAGLX has a PortfoliosLab risk / return rank of 90. There are 11 mutual funds in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.


Top Performing JAGLX Alternatives (YTD)

JAGLX is at 7.46% YTD. There are 23 mutual funds in the Health & Biotech Equities category with higher YTD returns, going as high as 21.62%.


Lowest Volatility Alternatives to JAGLX

JAGLX has 15.75% 1-year volatility. There are 14 mutual funds in the Health & Biotech Equities category with lower 1-year volatility, going as low as 14.34%.


Lowest Drawdown Alternatives to JAGLX

JAGLX has a 1-year max drawdown of -9.71%. There are 16 mutual funds in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -7.62%.


Other Mutual Funds from Janus Henderson

The 10 most viewed Janus Henderson mutual funds shown here include JNGTX, JNRFX, JAGTX and span 7 categories.


Often Compared With JAGLX

Investors most often compare JAGLX with JNGLX, VHT, IHE. These 20 comparison targets span 6 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
Janus Henderson Global Life Sciences FundHealth & Biotech Equities
91
7.53%
Dec 1998JAGLX vs JNGLX
Vanguard Health Care ETFHealth & Biotech Equities
64
6.71%
20.40BJan 2004JAGLX vs VHT
iShares U.S. Pharmaceuticals ETFHealth & Biotech Equities
94
20.10%
1.65BMay 2006JAGLX vs IHE
iShares U.S. Healthcare Providers ETFHealth & Biotech Equities
62
18.25%
1.25BMay 2006JAGLX vs IHF
VanEck Biotech ETFHealth & Biotech Equities
52
9.92%
399.88MDec 2011JAGLX vs BBH
Janus Henderson Global Life Sciences Fund Class AHealth & Biotech Equities
90
7.42%
Dec 1998JAGLX vs JFNAX
Fidelity Global ex U.S. Index FundForeign Large Cap Equities
74
14.36%
Aug 2011JAGLX vs FSGGX
iShares U.S. Healthcare ETFHealth & Biotech Equities
54
5.42%
3.56BJun 2000JAGLX vs IYH
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
80
12.77%
9.21BFeb 2001JAGLX vs IBB
iShares U.S. Medical Devices ETFHealth & Biotech Equities
5
-12.74%
3.25BMay 2006JAGLX vs IHI
Invesco DWA Basic Materials Momentum ETFMomentum, Materials
38
12.50%
72.14MOct 2006JAGLX vs PYZ
T. Rowe Price Health Sciences FundHealth & Biotech Equities
68
6.78%
Dec 1995JAGLX vs PRHSX
SPDR S&P Pharmaceuticals ETFHealth & Biotech Equities
93
24.89%
502.65MJun 2006JAGLX vs XPH
Janus Henderson VIT Global Technology and Innovati...Technology Equities
33
22.16%
Jan 2000JAGLX vs JGLTX
Janus Henderson Global Select FundGlobal Equities
44
10.18%
Jun 2000JAGLX vs JANRX
SPDR S&P Biotech ETFHealth & Biotech Equities
93
24.69%
9.90BFeb 2006JAGLX vs XBI
Eventide Healthcare & Life Sciences FundHealth & Biotech Equities
85
7.12%
Dec 2012JAGLX vs ETIHX
Vanguard Information Technology ETFTechnology Equities
58
27.80%
169.20BMar 2004JAGLX vs VGT
T. Rowe Price Science And Technology FundTechnology Equities
42
22.05%
Sep 1987JAGLX vs PRSCX
Fidelity Advisor Biotechnology Fund Class CHealth & Biotech Equities
92
19.33%
Dec 2000JAGLX vs FBTCX

Compare JAGLX with Any Fund or Stock

Compare JAGLX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair JAGLX with funds that move differently

Janus Henderson Global Life Sciences Fund Class T alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to JAGLX.

Explore JAGLX Diversifiers